SCHEMBL8154017

SCHEMBL8154017

Nc1c(F)c(F)c(S(=O)(=O)O)c(F)c1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 12/20 0.42
CA2 P00918 12/20 0.42
CA12 O43570 9/20 0.42
CA7 P43166 9/20 0.42
CA13 Q8N1Q1 9/20 0.42
F2 P00734 3/20 0.38
PRSS1 P07477 3/20 0.38
PRSS2 P07478 3/20 0.38
PRSS3 P35030 3/20 0.38
MMP1 P03956 1/20 0.37
MMP2 P08253 1/20 0.37
MMP9 P14780 1/20 0.37
MMP8 P22894 1/20 0.37
MMP13 P45452 1/20 0.37
DAPK1 P53355 1/20 0.36
CA9 Q16790 3/20 0.35
CA3 P07451 2/20 0.35
CA4 P22748 2/20 0.35
CA6 P23280 2/20 0.35
CA5A P35218 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18594452 0.95 CA1 (0.44) CA1CA2CA12CA7CA13
Ethane SCHEMBL28263202 0.95 CA1 (0.39) CA1CA2CA12CA7CA13
SCHEMBL18594499 0.89 CA1 (0.34) CA1CA2CA12CA7CA13
SCHEMBL9178730 0.87 CA1 (0.46) CA1CA2CA12CA7CA13
SCHEMBL2875483 0.86 CA2 (0.48) CA1CA2CA12CA7CA13
Sulfuric Acid SCHEMBL8646807 0.83 CA5A (0.40) CA1CA2CA12CA7CA13
SCHEMBL36242 0.83 CA2 (0.52) CA1CA2CA12CA7CA13
SCHEMBL21522351 0.80 CA2 (0.50) CA1CA2CA12CA7CA13
SCHEMBL21522547 0.80 CA2 (0.50) CA1CA2CA12CA7CA13
Ammonia Solution, Strong SCHEMBL21384843 0.80 CA2 (0.50) CA1CA2CA12CA7CA13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11258134-B2 Energy providing devices and applications thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-02-22 US disclosed
US-20200203692-A1 ENERGY PROVIDING DEVICES AND APPLICATIONS THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2020-06-25 US disclosed
US-10629880-B2 Energy providing devices and applications thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2020-04-21 US disclosed
US-10315169-B2 Universal scalable and cost-effective surface modifications THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2019-06-11 US disclosed
US-20180159106-A1 ENERGY PROVIDING DEVICES AND APPLICATIONS THEREOF NATIONAL SCIENCE FOUNDATION 2018-06-07 US disclosed
US-20170296986-A1 UNIVERSAL SCALABLE AND COST-EFFECTIVE SURFACE MODIFICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2017-10-19 US disclosed
US-20120082939-A1 ACTIVE LIGHT RAY SENSITIVE OR RADIOACTIVE RAY SENSITIVE RESIN COMPOSITION, AND ACTIVE LIGHT RAY SENSITIVE OR RADIOACTIVE RAY SENSITIVE FILM AND PATTERN FORMING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2012-04-05 US disclosed
EP-1026171-A1 Polymer modification PolyMASC Pharmaceuticals plc (GB) 2000-08-09 EP disclosed
EP-0714402-A1 POLYMER MODIFICATION PolyMASC Pharmaceuticals plc (GB) 1996-06-05 EP disclosed
WO-1995006058-A1 POLYMER MODIFICATION POLYMASC PHARMACEUTICALS PLC (GB) 1995-03-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200203692-A1 ENERGY PROVIDING DEVICES AND APPLICATIONS THEREOF PC, IDH2, MCU CA1 1077/4885CA2 1016/4885CA12 1179/4885
US-11258134-B2 Energy providing devices and applications thereof PC, IDH2, MCU CA1 1077/4885CA2 1016/4885CA12 1179/4885
US-20180159106-A1 ENERGY PROVIDING DEVICES AND APPLICATIONS THEREOF PC, IDH2, MCU CA1 1077/4885CA2 1016/4885CA12 1179/4885
US-20170296986-A1 UNIVERSAL SCALABLE AND COST-EFFECTIVE SURFACE MODIFICATIONS EPCAM, CD59, SIGLEC9 CA1 952/4885CA2 2460/4885CA12 130/4885
US-10315169-B2 Universal scalable and cost-effective surface modifications EPCAM, CD59, SIGLEC9 CA1 952/4885CA2 2460/4885CA12 130/4885
US-10629880-B2 Energy providing devices and applications thereof PC, IDH2, MCU CA1 1077/4885CA2 1016/4885CA12 1179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.